mhurhangee/ep-ind-claims huggingface dataset:
A method of laser cutting a coated substrate (10, 12); the method being characterised by the following steps: substantially removing a plurality of target portions of a polymer coating from a coated substrate (10, 12) to form a predetermined coating removal pattern by directing an ablative laser beam to the plurality of target portions, wherein the ablative laser beam has a wavelength that is absorbed by the polymer coating and wherein the substrate is a material transparent to the wavelength of the ablative laser beam; directing a cutting laser beam along the predetermined coating removal pattern; and separating the coated substrate (10, 12) into at least two coated parts, wherein the predetermined coating removal pattern has a width of between about 10 μm and about 6.0 mm. substantially removing a plurality of target portions of a polymer coating from a coated substrate (10, 12) to form a predetermined coating removal pattern by directing an ablative laser beam to the plurality of target portions, wherein the ablative laser beam has a wavelength that is absorbed by the polymer coating and wherein the substrate is a material transparent to the wavelength of the ablative laser beam; directing a cutting laser beam along the predetermined coating removal pattern; and separating the coated substrate (10, 12) into at least two coated parts, wherein the predetermined coating removal pattern has a width of between about 10 μm and about 6.0 mm.
A method of inactivation of plasmin enzyme in a milk-based product, comprising the steps of: - providing a milk raw material, - separating casein and whey protein from the milk raw material by microfiltration to provide a casein concentrate as a microfiltration retentate having a whey protein content of less than 20 wt%, specifically at most about 18 wt.%, more specifically at most about 14 wt.%, still more specifically at most about 12 wt.%, even more specifically at most about 6 wt.%, based on the total protein content of the concentrate, and a whey protein concentrate as a microfiltration permeate, - subjecting the casein concentrate to a thermal treatment at a temperature in the range of about 72°C to about 95°C, specifically at about 80°C to about 95°C, for about 30 sec to about 600 sec, to provide a thermally treated casein concentrate, - providing a milk-based product with a reduced plasmin activity by combining the thermally treated casein concentrate with whey protein, lactose, milk minerals and water, - subjecting the milk-based product to heat treatment selected from UHT treatment at 138°C to about 180°C for at least 3 sec, high pasteurization at 125°C to 138°C for 0.5 to 4 sec, pasteurization at 72°C to 75°C for 15 to 20 sec, thermisation at 57°C to 68°C for up to 40 minutes, heat treatment at least at 150°C for at most of 0.3 sec. - providing a milk raw material, - separating casein and whey protein from the milk raw material by microfiltration to provide a casein concentrate as a microfiltration retentate having a whey protein content of less than 20 wt%, specifically at most about 18 wt.%, more specifically at most about 14 wt.%, still more specifically at most about 12 wt.%, even more specifically at most about 6 wt.%, based on the total protein content of the concentrate, and a whey protein concentrate as a microfiltration permeate, - subjecting the casein concentrate to a thermal treatment at a temperature in the range of about 72°C to about 95°C, specifically at about 80°C to about 95°C, for about 30 sec to about 600 sec, to provide a thermally treated casein concentrate, - providing a milk-based product with a reduced plasmin activity by combining the thermally treated casein concentrate with whey protein, lactose, milk minerals and water, - subjecting the milk-based product to heat treatment selected from UHT treatment at 138°C to about 180°C for at least 3 sec, high pasteurization at 125°C to 138°C for 0.5 to 4 sec, pasteurization at 72°C to 75°C for 15 to 20 sec, thermisation at 57°C to 68°C for up to 40 minutes, heat treatment at least at 150°C for at most of 0.3 sec.
A powertrain, wherein the powertrain comprises an inverter, a motor, an electronic pump, a first cooling loop, and a controller, wherein coolant in the first cooling loop is configured to cool the inverter; the electronic pump is configured to drive the coolant to circulate in the first cooling loop; the inverter is configured to output an alternating current to the motor; and when a phase current of the motor is greater than or equal to a preset current value, the controller is configured to determine a rotation speed of the electronic pump at a first moment as a first rotation speed, and determine a coolant flow rate at the first moment based on a temperature at a first position in the first cooling loop, a temperature at a second position in the inverter, and a power loss of the inverter; and when the phase current of the motor is less than the preset current value, the controller is configured to determine a rotation speed of the electronic pump at a second moment as a second rotation speed, and determine a coolant flow rate at the second moment based on the first rotation speed, the coolant flow rate at the first moment, and the second rotation speed. coolant in the first cooling loop is configured to cool the inverter; the electronic pump is configured to drive the coolant to circulate in the first cooling loop; the inverter is configured to output an alternating current to the motor; and when a phase current of the motor is greater than or equal to a preset current value, the controller is configured to determine a rotation speed of the electronic pump at a first moment as a first rotation speed, and determine a coolant flow rate at the first moment based on a temperature at a first position in the first cooling loop, a temperature at a second position in the inverter, and a power loss of the inverter; and when the phase current of the motor is less than the preset current value, the controller is configured to determine a rotation speed of the electronic pump at a second moment as a second rotation speed, and determine a coolant flow rate at the second moment based on the first rotation speed, the coolant flow rate at the first moment, and the second rotation speed.
Yeast autolysate having a dry solids ratio of ≥50% and ≤95% based on sodium chloride free dry matter of the yeast autolysate and comprising at least 0.75% w/w 5'-GMP on sodium chloride free dry matter of the yeast autolysate, wherein the dry solids ratio is defined as the ratio between solubilised solids and total solids of the yeast autolysate.
A method of forming a control signal for a wireless communication system by a first terminal and a second terminal among a plurality of terminals that commonly use a resource having a frequency domain and a time domain, the method comprising: multiplying a code that is determined by a cyclic shift index and a time domain orthogonal cover index of length 4, by a control signal to be transmitted to a base station in a first slot; and multiplying a code that is determined by a cyclic shift index that is different from the cyclic shift index of the first slot and a time domain orthogonal cover index of length 4, by a control signal to be transmitted to the base station in a second slot, characterised in that when the same cyclic shift index is allocated to the first terminal and the second terminal in the first slot, a sequence for the time domain orthogonal cover index of the first terminal and a sequence for the time domain orthogonal cover index of the second terminal have orthogonality of a length 2 in the first slot or when the same time domain orthogonal cover index is allocated to the first terminal and the second terminal in the first slot, a difference between the cyclic shift index of the first slot allocated to the first terminal and the cyclic shift index of the first slot allocated to the second terminal is equal to or greater than 2. multiplying a code that is determined by a cyclic shift index and a time domain orthogonal cover index of length 4, by a control signal to be transmitted to a base station in a first slot; and multiplying a code that is determined by a cyclic shift index that is different from the cyclic shift index of the first slot and a time domain orthogonal cover index of length 4, by a control signal to be transmitted to the base station in a second slot, characterised in that when the same cyclic shift index is allocated to the first terminal and the second terminal in the first slot, a sequence for the time domain orthogonal cover index of the first terminal and a sequence for the time domain orthogonal cover index of the second terminal have orthogonality of a length 2 in the first slot or when the same time domain orthogonal cover index is allocated to the first terminal and the second terminal in the first slot, a difference between the cyclic shift index of the first slot allocated to the first terminal and the cyclic shift index of the first slot allocated to the second terminal is equal to or greater than 2.
A sanitary napkin having a longitudinal axis defining a longitudinal orientation and longitudinally-oriented side edges, a transverse axis orthogonal to said longitudinal axis, a thickness measured orthogonal to a plane defined by said longitudinal axis and said transverse axis, said sanitary napkin comprising: a facing layer joined to a backsheet, and an absorbent core disposed between said facing layer and said backsheet; said facing layer comprising a first region comprising a plurality of apertures; and a second region comprising a plurality of out-of-plane deformations, wherein said out-of-plane deformations are individual rib-like elements all having a length of between 1% and 50% of the length of said sanitary napkin said sanitary napkin being characterized in that said individual rib-like elements are disposed along said longitudinally-oriented side edges of said sanitary napkin, and in that said first region is disposed centrally to said sanitary napkin and said second region is disposed adjacent at least one of said side edges of said sanitary napkin. a facing layer joined to a backsheet, and an absorbent core disposed between said facing layer and said backsheet; said facing layer comprising a first region comprising a plurality of apertures; and a second region comprising a plurality of out-of-plane deformations, wherein said out-of-plane deformations are individual rib-like elements all having a length of between 1% and 50% of the length of said sanitary napkin said sanitary napkin being characterized in that said individual rib-like elements are disposed along said longitudinally-oriented side edges of said sanitary napkin, and in that said first region is disposed centrally to said sanitary napkin and said second region is disposed adjacent at least one of said side edges of said sanitary napkin.
A functional film manufacturing method, in manufacturing a functional film having an organic layer on a support and an inorganic layer on the organic layer, comprising the steps of: preparing a coating material containing an organic compound which has a glass transition temperature of 100°C or higher and is to be the organic layer, and an organic solvent; coating a surface of the support with the coating material in an amount of 5 cc/m 2 or more such that a thickness of the organic layer becomes 0.05 to 3 μm; forming the organic layer by drying the coating material coated on the surface of the support such that the coating material has a viscosity of 20 cP or higher and a surface tension of 34 mN/m or less in a decreasing-rate-of-drying state, and then curing the organic compound; and forming the inorganic layer on a surface of the formed organic layer by a vapor phase deposition method accompanied by generation of plasma. preparing a coating material containing an organic compound which has a glass transition temperature of 100°C or higher and is to be the organic layer, and an organic solvent; coating a surface of the support with the coating material in an amount of 5 cc/m 2 or more such that a thickness of the organic layer becomes 0.05 to 3 μm; forming the organic layer by drying the coating material coated on the surface of the support such that the coating material has a viscosity of 20 cP or higher and a surface tension of 34 mN/m or less in a decreasing-rate-of-drying state, and then curing the organic compound; and forming the inorganic layer on a surface of the formed organic layer by a vapor phase deposition method accompanied by generation of plasma.
A system for controlling sample preparation comprising a microscope configured with a camera to provide images of a biological sample and having an image analysis module configured to analyze images from the camera, the device characterized by: the image analysis module configured to monitor the images from the camera for a detectable biological event; a fluidics activation module configured to be activated by the image analysis module if the detectable biological event occurs, wherein the activation results in the treatment of the biological sample. the image analysis module configured to monitor the images from the camera for a detectable biological event; a fluidics activation module configured to be activated by the image analysis module if the detectable biological event occurs, wherein the activation results in the treatment of the biological sample.
Apparatus for a vacuum cleaner for compensating air pressure fluctuations, having a main body through which an air flow can flow in a flow direction, characterized in that the main body contains at least one passage opening, and in that a separating element for separating the passage opening from ambient air is included, wherein the separating element is movable to ensure that a reservoir to receive an air volume is produced between the main body and the separating element, and a vacuum produced in the main body by the air flow is at least partially maintained.
A pressure control system, comprising: an overboard valve configured to be in indirect communication with a first enclosed environment and in direct communication with a second enclosed environment; wherein the first environment is suitable for human occupancy and configured to receive pressurized air from an environmental control system; wherein the second environment is configured to receive the pressurized air from the first environment; an inboard valve configured to supply a discharge of pressurized air from the second environment; an outflow valve configured to regulate a discharge of air from the first environment to an area outside the first and second environments; a positive pressure relief valve configured to regulate a discharge of air from the first environment; a negative pressure relief valve configured to regulate an ingress of air into the first environment; and a control valve configured to supply and regulate pressurized air from the first environment to a compressor. an overboard valve configured to be in indirect communication with a first enclosed environment and in direct communication with a second enclosed environment; wherein the first environment is suitable for human occupancy and configured to receive pressurized air from an environmental control system; wherein the second environment is configured to receive the pressurized air from the first environment; an inboard valve configured to supply a discharge of pressurized air from the second environment; an outflow valve configured to regulate a discharge of air from the first environment to an area outside the first and second environments; a positive pressure relief valve configured to regulate a discharge of air from the first environment; a negative pressure relief valve configured to regulate an ingress of air into the first environment; and a control valve configured to supply and regulate pressurized air from the first environment to a compressor.
Process for obtaining RNA in a dissolved fraction and DNA in an undissolved fraction from the same biological sample fixed by crosslinking, comprising the following steps: a) partial dissolution of the sample in an aqueous buffer solution with simultaneous partial proteolysis of the protein-containing components of the sample using at least one proteolytically active compound to obtain a dissolved fraction (fraction A) and an undissolved residue (pellet; fraction B), b) separation of the dissolved fraction from the undissolved residue, wherein the dissolved fraction comprises mainly RNA, based on the total amount of nucleic acids in the dissolved fraction, and the undissolved residue comprises mainly DNA, based on the total amount of nucleic acids in the undissolved residue, wherein the separation of the fraction comprising predominantly RNA from the fraction comprising predominantly DNA requires neither precipitation nor extraction of one or both types of nucleic acid with organic solvents nor selective binding of one or both types of nucleic acid to a solid matrix. a) partial dissolution of the sample in an aqueous buffer solution with simultaneous partial proteolysis of the protein-containing components of the sample using at least one proteolytically active compound to obtain a dissolved fraction (fraction A) and an undissolved residue (pellet; fraction B), b) separation of the dissolved fraction from the undissolved residue,
A nitride semiconductor light-emitting element comprising: an n-type nitride semiconductor layer (105, 106); a nitride semiconductor active layer provided on said n-type nitride semiconductor layer (105, 106); and a p-type nitride semiconductor layer (108, 109, 110, 111) provided on said nitride semiconductor active layer, wherein said p-type nitride semiconductor layer (108, 109, 110, 111) includes a first p-type nitride semiconductor layer, a second p-type nitride semiconductor layer and a third p-type nitride semiconductor layer in this order from the side of said nitride semiconductor active layer, said first p-type nitride semiconductor layer and said second p-type nitride semiconductor layer contain Al respectively, an absolute value of a difference between an average Al composition in a material which said first p-type nitride semiconductor layer is composed of, and an average Al composition in a material which said second p-type nitride semiconductor layer is composed of, is at most 0.02, said third p-type nitride semiconductor layer has a smaller band gap than said second p-type nitride semiconductor layer, and the p-type impurity concentration in said second p-type nitride semiconductor layer and the p-type impurity concentration in said third p-type nitride semiconductor layer are lower than the p-type impurity concentration in said first p-type nitride semiconductor layer respectively. an n-type nitride semiconductor layer (105, 106); a nitride semiconductor active layer provided on said n-type nitride semiconductor layer (105, 106); and a p-type nitride semiconductor layer (108, 109, 110, 111) provided on said nitride semiconductor active layer, wherein said p-type nitride semiconductor layer (108, 109, 110, 111) includes a first p-type nitride semiconductor layer, a second p-type nitride semiconductor layer and a third p-type nitride semiconductor layer in this order from the side of said nitride semiconductor active layer, said first p-type nitride semiconductor layer and said second p-type nitride semiconductor layer contain Al respectively, an absolute value of a difference between an average Al composition in a material which said first p-type nitride semiconductor layer is composed of, and an average Al composition in a material which said second p-type nitride semiconductor layer is composed of, is at most 0.02, said third p-type nitride semiconductor layer has a smaller band gap than said second p-type nitride semiconductor layer, and the p-type impurity concentration in said second p-type nitride semiconductor layer and the p-type impurity concentration in said third p-type nitride semiconductor layer are lower than the p-type impurity concentration in said first p-type nitride semiconductor layer respectively.
An agent for use in the therapeutic and/or prophylactic treatment of a cancer(s), the agent comprising as an effective ingredient any one of the polypeptides (a) or(b) below, said polypeptide having cytotoxicity-inducing activity of inducing cytotoxic activity against tumor cells in vitro in T cells stimulated with the polypeptide, or as an effective ingredient a recombinant vector which comprises a polynucleotide encoding said polypeptide and is capable of expressing said polypeptide in vivo: (a) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 16 or 18 in SEQUENCE LISTING; and (b) a polypeptide having a sequence identity of not less than 90% to the polypeptide (a). (a) a polypeptide consisting of the amino acid sequence shown in SEQ ID NO: 16 or 18 in SEQUENCE LISTING; and (b) a polypeptide having a sequence identity of not less than 90% to the polypeptide (a).
A surgical forceps comprising: a forceps jaw that engages a tissue of a body, the forceps jaw comprising a surface; a first pattern of traces formed in the surface in a first direction, a first spacing between adjacent traces of the first pattern of traces being within a range of 5.5 μm to 15 μm; characterized by a second pattern of traces formed in the surface in a second direction different from the first direction, a second spacing between adjacent traces of the second pattern of traces being within a range of 5.5 μm to 15 μm, the first pattern of traces and the second pattern of traces defining an array of microposts, the microposts of the array of microposts having a height within a range of 3 μm to 10 μm, wherein one or more of the microposts of the array of microposts are inclined at an angle (α) within a range of 20° to 55° relative to the surface of the forceps jaw. a forceps jaw that engages a tissue of a body, the forceps jaw comprising a surface; a first pattern of traces formed in the surface in a first direction, a first spacing between adjacent traces of the first pattern of traces being within a range of 5.5 μm to 15 μm; characterized by a second pattern of traces formed in the surface in a second direction different from the first direction, a second spacing between adjacent traces of the second pattern of traces being within a range of 5.5 μm to 15 μm, the first pattern of traces and the second pattern of traces defining an array of microposts, the microposts of the array of microposts having a height within a range of 3 μm to 10 μm, wherein one or more of the microposts of the array of microposts are inclined at an angle (α) within a range of 20° to 55° relative to the surface of the forceps jaw.
An article comprising: a substrate comprising a precipitate-strengthened alloy, the alloy comprising a) a population of gamma-prime precipitates, the population having a multimodal size distribution with at least one mode corresponding to a size of less than 100 nanometers; or b) a population of gamma-double-prime precipitates having a median size less than 300 nanometers; and a coating disposed over the substrate, wherein the coating comprises aluminum, chromium, and M, wherein M is at least one element selected from the group consisting of nickel, cobalt, and iron; wherein the coating further comprises a plurality of prior particle boundaries; and wherein at least a portion of the coating is free of rapid solidification artifacts. a substrate comprising a precipitate-strengthened alloy, the alloy comprising a) a population of gamma-prime precipitates, the population having a multimodal size distribution with at least one mode corresponding to a size of less than 100 nanometers; or b) a population of gamma-double-prime precipitates having a median size less than 300 nanometers; a) a population of gamma-prime precipitates, the population having a multimodal size distribution with at least one mode corresponding to a size of less than 100 nanometers; or b) a population of gamma-double-prime precipitates having a median size less than 300 nanometers; and a coating disposed over the substrate,